awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q50445091-29A4082D-E43F-442A-B32E-5E86D9DBA1FF
Q50445091-29A4082D-E43F-442A-B32E-5E86D9DBA1FF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50445091-29A4082D-E43F-442A-B32E-5E86D9DBA1FF
Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab.
P2860
Q50445091-29A4082D-E43F-442A-B32E-5E86D9DBA1FF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50445091-29A4082D-E43F-442A-B32E-5E86D9DBA1FF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7b63391b3c229c36ddc69542acc8d4f7c5957696
P2860
Long-term efficacy of the complement inhibitor eculizumab in cold agglutinin disease